@onwdempowered and our Research Partners have won first place in the 2022 Brain-Computer Interface Award, one of the top accolades in #BCI research. We hope a BCI platform will optimize the effectiveness of our therapies to restore movement for people living with #paralysis.”
We are thrilled to welcome Lara Smith Weber as ONWARD’s new Chief Financial Officer. She brings tremendous experience as a global finance leader, having led a $240M NASDAQ IPO for MorphoSys, Inc. in 2018.
To learn more about @onwdempowered please visit https://t.co/vnrI8RRmMS
The @onwdempowered team celebrates the first-in-human use of our ARC-IM IPG, the first neurostimulator purpose-designed for #spinalcordinjury-related therapies. We are motivated by our commitment to help people living with #SCI enjoy life in every way that matters to them!
Today ONWARD's ARC-IM IPG, the first neurostimulator designed for SCI, was implanted in a human for the first time by Dr. @Jocelyne_Bloch. This first-in-human implant was also the first enrollment in our HemON study to assess blood pressure and trunk control in people with #SCI.
Today we published our 2021 financial results and filed our first Annual Report as a listed company. We are proud of our 2021 full year financial & operating achievements. Read about highlights & access the Annual Report at https://t.co/DmiJHIW8vX
#medtech#businessupdate#sci
Dr. Jill Wecht of @MountSinaiNYC and the Bronx #VA discusses how #spinalcordinjury affects autonomic function and how ARC Therapy may be able to normalize blood pressure in individuals with #SCI in this episode of Onward with Scott Chesney
https://t.co/JBXb8G0kHe
@onwdempowered
@scottchesney speaks with @ReeveFoundation CEO @Maggie718 about the importance of translating groundbreaking research into commercially available therapies for people living with #spinalcordinjury in the latest episode of Onward with Scott Chesney.
https://t.co/wHMjMVgSWh
@onwdempowered CEO Dave Marver presented ONWARD’s vision to translate groundbreaking research to clinical care for people living with #spinalcordinjury at #BioCapital Europe 2022, organized by #EQT Life Sciences (formerly LSP).
#SCI#Medtech
@onwdempowered is pleased to announce the start of the LIFT Home Study. This trial will study the safety and performance of ARC-EX Therapy when used at home, and will be conducted at 5 US research centers: @CraigHospital, @ShepherdCenter, @SpauldingRehab, @UMNews, and @UW
In this episode of Onward with @scottchesney, Scott speaks with @onwdempowered CEO Dave Marver about the company’s vision and progress towards translating research into commercially available therapies for people with #spinalcordinjury.
https://t.co/d0QF9NHl2b #SCI#neurorehab